These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 803223)

  • 21. Reversal by phenylephrine of the beneficial effects of intravenous nitroglycerin in patients with acute myocardial infarction.
    Come PC; Flaherty JT; Baird MG; Rouleau JR; Weisfeldt ML; Greene HL; Becker L; Pitt B
    N Engl J Med; 1975 Nov; 293(20):1003-7. PubMed ID: 809711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

  • 23. Autonomic neural control during acute myocardial ischemia after phenylephrine infusion and subsequent nitroglycerin-induced hypotension and bradycardia.
    Del Greco M; Nollo G; Disertori M
    G Ital Cardiol; 1999 Jan; 29(1):76-80. PubMed ID: 9987052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasodilators in the management of acute myocardial infarction.
    Epstein SE; Kent KM; Borer JS; Goldstein RE; Smith HJ; Capurro NL
    Adv Cardiol; 1978; (22):138-46. PubMed ID: 413333
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitroglycerin therapy in acute myocardial infarction--an overview.
    Bussmann WD
    Z Kardiol; 1983; 72 Suppl 3():137-40. PubMed ID: 6421005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
    Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL
    J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of propranolol and nitroglycerin plus methoxamine on transmural creatine kinase activity after acute coronary occlusion.
    Jesmok GJ; Gross GJ; Hardman HF
    Am J Cardiol; 1978 Nov; 42(5):769-73. PubMed ID: 101067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intravenous nitroglycerin in the treatment of cardiac insufficiency].
    Carvalho MA; Osterne EC; Carvalho PR; Aloan L; Carneiro RD
    Arq Bras Cardiol; 1977 Apr; 30(2):123-5. PubMed ID: 410392
    [No Abstract]   [Full Text] [Related]  

  • 29. Beneficial electrophysiologic effects of nitroglycerin during acute myocardial infarction.
    Kent KM; Smith ER; Redwood DR; Epstein SE
    Am J Cardiol; 1974 Apr; 33(4):513-6. PubMed ID: 4206442
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of experimental myocardial infarct size by cardiac drugs.
    Puri PS
    Am J Cardiol; 1974 Apr; 33(4):521-8. PubMed ID: 4818050
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of nitroglycerine administered by intravenous infusion upon coronary flow and cardiac metabolism. Continuous study during experimental myocardial infarction].
    Cahn J; Angignard J; Pawelec C; Lebeau M; Weber S
    Nouv Presse Med; 1979 Jan; 8(4):239-49. PubMed ID: 122014
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
    Sapozhikov AV
    Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of nitroglycerin on the ventricular function, coronary circulation and oxygen consumption of the left ventricle under constant arterial pressure and heart rate].
    Strauer BE; Höfling B; Scherpe A
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1126-8. PubMed ID: 829459
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of nitroglycerin on regional myocardial blood flow abnormality induced by atrial pacing; a clinical study in myocardial infarction (author's transl)].
    Naka M; Tsuji K; Arai H
    Kokyu To Junkan; 1982 Feb; 30(2):173-81. PubMed ID: 6805060
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitroglycerin in acute myocardial infarction.
    Jugdutt BI
    Can J Cardiol; 1989 Mar; 5(2):110-6. PubMed ID: 2495850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influencing of the circulation rate and oxygen metabolism in the ischemic myocardium. Comparison with the effect on the normal myocardium].
    Parrat JR; Marshall RJ; Ledingham IM
    Med Welt; 1974 Jul; 25(26):1152-5. PubMed ID: 4152465
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog.
    Jugdutt BI; Becker LC; Hutchins GM; Bulkley BH; Reid PR; Kallman CH
    Circulation; 1981 Jan; 63(1):17-28. PubMed ID: 6777074
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.